Clinical trialNCT03774797CompletedObservational

Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation

SponsorUniversity of MichiganEnrollment592Pregnancy Related

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unintended pregnancy soon after childbirth by increasing access to immediate postpartum LARC for women who desire it.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michelle H. Moniz, MD, MSc
University of Michigan
Principal Investigator
clinicaltrials.gov ↗
Michelle Heisler, MD, MPH
University of Michigan
Principal Investigator
clinicaltrials.gov ↗
Vanessa K. Dalton, MD, MPH
University of Michigan
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Michigan Medicine
Ann Arbor, Michigan, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Sept 2018
Primary completion: 16 Aug 2020
Completion: 16 Aug 2020
Last update posted: 12 Feb 2021
Registered enrollment: 592
Registry id: NCT03774797

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.